NEW YORK, December 29, 2025, 01:59 ET — Market closed.
- Hims & Hers shares last closed down 1% at $34.31, extending a four-session slide.
- The company has outlined a $200 million-plus Ohio expansion aimed at adding fulfillment, lab testing and pharmacy capacity.
- Traders head into a holiday-shortened week with U.S. pending home sales due Monday and Fed minutes due Tuesday.
Hims & Hers Health Inc shares last closed down about 1% at $34.31 on Friday, extending a four-session slide as U.S. markets headed into the final trading days of the year.
The move matters now because year-end trading typically brings lighter volumes and sharper swings, leaving growth stocks sensitive to shifts in rate expectations and risk appetite.
For Hims & Hers, investors have also been parsing how quickly the telehealth company can scale its physical operations as it pushes deeper into higher-touch care that relies on pharmacy and lab infrastructure.
The company said on December 17 it plans to invest more than $200 million to expand operations in New Albany, Ohio, with a new facility focused on fulfillment, lab testing and pharmacy operations.
The project is expected to double the company’s physical footprint in the Columbus region and create up to 400 new jobs, the press release said.
“As more customers come to Hims & Hers to access the care they need, we’re growing our ability to meet demand,” Chief Operating Officer Mike Chi said. The Columbus Region
The new site is slated for 9885 Innovation Campus Way in New Albany, with construction expected to begin in the first quarter of 2026, the release said. It added that JobsOhio plans to provide assistance for the project that will be made public after a final agreement is executed.
On Friday, the stock traded between $33.52 and $34.71, with about 9.9 million shares changing hands, according to market data.
In the broader digital-health group, Teladoc Health and LifeMD also finished lower in the last session, as investors remained cautious on rate-sensitive names into year-end.
U.S. equities face a thin slate of company news in the final week of the year, with attention turning to the economic calendar and policy signals.
Before next session, traders will watch the National Association of Realtors’ pending home sales index for November due at 10:00 a.m. ET on Monday for clues on the housing market and consumer demand.
Minutes from the Federal Reserve’s December policy meeting are due Tuesday, another potential catalyst for rate expectations that can ripple through high-valuation growth stocks.
Markets are also moving into a holiday schedule: U.S. stock markets are set to trade a full day on Wednesday, December 31, and close on Thursday, January 1 for New Year’s Day, while bond markets are expected to close early on December 31.
For Hims & Hers, investors are likely to focus next on any timeline and spending details tied to the Ohio facility, and on the company’s next quarterly update for signs that added capacity can support growth without squeezing margins.
Near-term, traders will also be watching whether the stock can reclaim the $35 area and hold above last week’s low around $33.50.
